Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference
Wednesday, January 7, 2026 1 min read
Key Takeaway: Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced its participation in the 44th Annual J.P. Morgan Healthcare Conference scheduled for January 12, 2026. During the conference, Kiniksa will present at 2:15 p.m. Pacific Time. A live webcast of the presentation will be available on the company’s website, with a replay accessible within 48 hours post-event. Kiniksa is focused on developing therapies for diseases with unmet needs, particularly in the cardiovascular sector.
Market Sentiment Analysis
POSITIVE FACTORS
Kiniksa Pharmaceuticals is participating in a prestigious healthcare conference.
The company's focus on novel therapies for unmet needs highlights its innovative approach.
Kiniksa aims to improve the lives of patients with debilitating diseases.
Full Press Release Details
LONDON, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 2:15 p.m. Pacific Time (5:15 p.m. Eastern Time).
A live webcast of Kiniksa’s presentation will be accessible through the Investors section of the company’s website at www.kiniksa.com. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.
Kiniksa is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa’s portfolio of assets is based on strong biologic rationale or validated mechanisms and offers the potential for differentiation. For more information, please visit www.kiniksa.com.